Early postnatal lipopolysaccharide exposure leads to enhanced neurogenesis and impaired communicative functions in rats

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Pang, Yi ^a   Dai, Xuemei ^a   Roller, Anna ^a   Carter, Kathleen ^a   Paul, Ian ^a   Bhatt, Abhay J ^a   Lin, Rick C S ^a   Fan, Lir Wan ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD206 PROTEIN; CELL PROTEIN; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL LINEAGE; CELL PROLIFERATION; COGNITIVE DEFECT; COMMUNICATION DISORDER; CONTROLLED STUDY; DENTATE GYRUS; EXPOSURE; FEMALE; GRAY MATTER; HIPPOCAMPUS; MALE; MICROGLIA; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PERINATAL PERIOD; PHENOTYPE; POSTNATAL EXPOSURE; RAT; SUBVENTRICULAR ZONE; UPREGULATION; WHITE MATTER; ANIMAL; ANIMAL COMMUNICATION; AUTISM; CHEMICALLY INDUCED; COGNITION; DRUG EFFECTS; INFLAMMATION; LATERAL BRAIN VENTRICLE; METABOLISM; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMAL COMMUNICATION; ANIMALS; ANIMALS, NEWBORN; AUTISM SPECTRUM DISORDER; COGNITION; DENTATE GYRUS; GRAY MATTER; INFLAMMATION; LATERAL VENTRICLES; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MANNOSE-BINDING LECTINS; MICROGLIA; NEUROGENESIS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; TRANSFORMING GROWTH FACTOR BETA; WHITE MATTER;

EID: 84991463652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164403     Document Type: Article

References (52)

1. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110-24. Epub 2008/12/17. doi: S1474-4422 (08) 70294-1 [pii] doi: 10.1016/S1474-4422 (08) 70294-1 PMID: 19081519; PubMed Central PMCID: PMC2707149.
2. Aylward GP. Neurodevelopmental outcomes of infants born prematurely. J Dev Behav Pediatr. 2016;35(6):394-407. Epub 2014/07/10. doi: 10.1097/01. DBP.0000452240.39511.d4 00004703-201407000-00007 [pii]. PMID: 25007063.
3. Anderson PJ. Neuropsychological outcomes of children born very preterm. Semin Fetal Neonatal Med. 2014;19(2):90-6. Epub 2013/12/24. S1744-165X (13) 00121-2 [pii] doi: 10.1016/j.siny.2013.11. 012 PMID: 24361279.
4. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson RL Jr., Moore M, et al. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics. 2008;121(4):758-65. Epub 2008/04/03. 121/4/758 [pii] doi: 10.1542/peds.2007-2158 PMID: 18381541; PubMed Central PMCID: PMC2703587.
5. Pinto-Martin JA, Levy SE, Feldman JF, Lorenz JM, Paneth N, Whitaker AH. Prevalence of autism spectrum disorder in adolescents born weighing <2000 grams. Pediatrics. 2011;128(5):883-91. Epub 2011/10/19. peds.2010-2846 [pii] doi: 10.1542/peds.2010-2846 PMID: 22007018; PubMed Central PMCID: PMC3208957.
6. Dammann O, Allred EN, Fichorova RN, Kuban K, O'Shea TM, Leviton A. Duration of Systemic Inflammation in the First Postnatal Month Among Infants Born Before the 28th Week of Gestation. Inflammation. 2016;39(2):672-7. Epub 2015/12/18. doi: 10.1007/s10753-015-0293-z [pii]. PMID: 26676589.
7. Knuesel I, Chicha L, Britschgi M, Schobel SA, Bodmer M, Hellings JA, et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol. 2014;10(11):643-60. Epub 2014/10/15. nrneurol.2014.187 [pii] doi: 10.1038/nrneurol.2014.187 PMID: 25311587.
8. Kinney HC, Volpe JJ. Modeling the encephalopathy of prematurity in animals: the important role of translational research. Neurol Res Int. 2012;2012:295389. Epub 2012/06/12. doi: 10.1155/2012/295389 PMID: 22685653; PubMed Central PMCID: PMC3366246.
9. Miller SP, Ferriero DM, Leonard C, Piecuch R, Glidden DV, Partridge JC, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr. 2005;147(5):609-16. Epub 2005/11/18. S0022-3476 (05) 00589-5 [pii] doi: 10.1016/j.jpeds.2005.06.033 PMID: 16291350.
10. Chau V, Poskitt KJ, McFadden DE, Bowen-Roberts T, Synnes A, Brant R, et al. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol. 2009;66(2):155-64. Epub 2009/09/11. doi: 10.1002/ana.21713 PMID: 19743455.
11. Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage? Trends Neurosci. 2001;24(6):320-4. Epub 2001/05/18. S0166-2236 (00) 01811-7 [pii]. doi: 10.1016/s0166-2236 (00) 01811-7 PMID: 11356502.
12. Leviton A, Allred EN, Dammann O, Engelke S, Fichorova RN, Hirtz D, et al. Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol. 2013;28(12):1637-45. Epub 2012/11/01. 0883073812463068 [pii] doi: 10.1177/0883073812463068 PMID: 23112243; PubMed Central PMCID: PMC4166653.
13. Pang Y, Cai Z, Rhodes PG. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res. 2003;140(2):205-14. Epub 2003/02/15. S0165380602006065 [pii]. doi: 10.1016/s0165-3806 (02) 00606-5 PMID: 12586426.
14. Pang Y, Fan LW, Zheng B, Cai Z, Rhodes PG. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience. 2006;141(2):745-55. Epub 2006/05/23. S0306-4522 (06) 00479-9 [pii] doi: 10.1016/j.neuroscience.2006.04.007 PMID: 16713113.
15. Pang Y, Fan LW, Zheng B, Campbell LR, Cai Z, Rhodes PG. Dexamethasone and betamethasone protect against lipopolysaccharide-induced brain damage in neonatal rats. Pediatr Res. 2012;71(5):552-8. Epub 2012/02/09. pr20129 [pii] doi: 10.1038/pr.2012.9 PMID: 22314662; PubMed Central PMCID: PMC3609027.
16. Fan LW, Tien LT, Zheng B, Pang Y, Lin RC, Simpson KL, et al. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav Immun. 2011;25(2):286-97. Epub 2010/09/30. S0889-1591 (10) 00501-5 [pii] doi: 10.1016/j.bbi. 2010.09.020 PMID: 20875849; PubMed Central PMCID: PMC3025048.
17. Back SA. Brain Injury in the Preterm Infant: New Horizons for Pathogenesis and Prevention. Pediatr Neurol. 2015;53(3):185-92. Epub 2015/08/26. S0887-8994 (15) 00215-5 [pii] doi: 10.1016/j. pediatrneurol.2015.04.006 PMID: 26302698; PubMed Central PMCID: PMC4550810.
18. Fan LW, Bhatt A, Tien LT, Zheng B, Simpson KL, Lin RC, et al. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem. 2015;133(4):532-43. Epub 2014/11/11. doi: 10.1111/jnc.12988 PMID: 25382136; PubMed Central PMCID: PMC4400220.
19. Borta A, Wohr M, Schwarting RK. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior. Behav Brain Res. 2006;166(2):271-80. Epub 2005/10/11. S0166-4328 (05) 00360-8 [pii] doi: 10.1016/j.bbr.2005.08.009 PMID: 16213033.
20. Wohr M. Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T+tf/J mouse model for autism. Front Neurosci. 2015;9:73. Epub 2015/04/09. doi: 10.3389/fnins.2015.00073 PMID: 25852455; PubMed Central PMCID: PMC4364166.
21. Jha MK, Lee WH, Suk K. Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders. Biochem Pharmacol. 2016;103:1-16. Epub 2015/11/12. S0006-2952 (15) 00712-1 [pii] doi: 10.1016/j.bcp. 2015.11.003 PMID: 26556658.
22. McQuillen PS, Ferriero DM. Selective vulnerability in the developing central nervous system. Pediatr Neurol. 2004;30(4):227-35. Epub 2004/04/17. doi: 10.1016/j.pediatrneurol.2003.10.001 S0887899403005319 [pii]. PMID: 15087099.
23. Casaccia-Bonnefil P. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia. 2000;29(2):124-35. Epub 2000/01/14. doi: 10.1002/(SICI) 1098-1136 (20000115) 29:2<124::AID-GLIA5>3.0. CO;2-O [pii]. PMID: 10625330.
24. Nunez JL, Lauschke DM, Juraska JM. Cell death in the development of the posterior cortex in male and female rats. J Comp Neurol. 2001;436(1):32-41. Epub 2001/06/20. doi: 10.1002/cne.1051.abs PMID: 11413544.
25. Kaushik G, Zarbalis KS. Prenatal Neurogenesis in Autism Spectrum Disorders. Front Chem. 2016;4:12. Epub 2016/03/26. doi: 10.3389/fchem.2016.00012 PMID: 27014681; PubMed Central PMCID: PMC4791366.
26. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, et al. Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011;306(18):2001-10. Epub 2011/11/10. 306/18/2001 [pii] doi: 10.1001/jama.2011.1638 PMID: 22068992.
27. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain. 1998;121(Pt 5):889-905. Epub 1998/06/10. doi: 10.1093/brain/121.5.889 PMID: 9619192.
28. Wegiel J, Kuchna I, Nowicki K, Imaki H, Marchi E, Ma SY, et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010;119(6):755-70. Epub 2010/03/04. doi: 10.1007/s00401-010-0655-4 PMID: 20198484; PubMed Central PMCID: PMC2869041.
29. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience. 2010;166(2):464-75. Epub 2009/12/29. S0306-4522 (09) 02075-2 [pii] doi: 10.1016/j.neuroscience.2009.12.040 PMID: 20035837.
30. Gottschall PE, Komaki G, Arimura A. Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Neuroendocrinology. 1992;56(6):935-8. Epub 1992/12/01. doi: 10.1159/000126328 PMID: 1369606.
31. Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun. 2010;24(1):102-9. Epub 2009/09/09. S0889-1591 (09) 00422-X [pii] doi: 10.1016/j.bbi.2009.09.001 PMID: 19735725; PubMed Central PMCID: PMC2789209.
32. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology. 2004;201(1-3):197-207. Epub 2004/08/07. doi: 10.1016/j.tox.2004.04.015 S0300483X04002689 [pii]. PMID: 15297033.
33. Chakravarty S, Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci. 2005;25(7):1788-96. Epub 2005/02/18. 25/7/1788 [pii] doi: 10.1523/JNEUROSCI.4268-04.2005 PMID: 15716415.
34. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, et al. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32(34):11706-15. Epub 2012/08/24. 32/34/11706 [pii] doi: 10.1523/JNEUROSCI.0730-12.2012 PMID: 22915113; PubMed Central PMCID: PMC4461442.
35. Biber K, Owens T, Boddeke E. What is microglia neurotoxicity (Not)? Glia. 2014;62(6):841-54. Epub 2014/03/05. doi: 10.1002/glia.22654 PMID: 24590682.
36. Olah M, Biber K, Vinet J, Boddeke HW. Microglia phenotype diversity. CNS Neurol Disord Drug Targets. 2011;10(1):108-18. Epub 2010/12/15. BSP/CDTCNSND/E-Pub/00092 [pii]. doi: 10.2174/187152711794488575 PMID: 21143141.
37. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, et al. Cell death in the oligodendrocyte lineage. J Neurobiol. 1992;23(9):1221-30. Epub 1992/11/01. doi: 10.1002/neu. 480230912 PMID: 1469385.
38. Ribeiro Xavier AL, Kress BT, Goldman SA, Lacerda De Menezes JR, Nedergaard M. A Distinct Population of Microglia Supports Adult Neurogenesis in the Subventricular Zone. J Neurosci. 2015;35(34):11848-61. Epub 2015/08/28. 35/34/11848 [pii] doi: 10.1523/JNEUROSCI.1217-15.2015 PMID: 26311768; PubMed Central PMCID: PMC4549398.
39. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci. 2006;31(1):149-60. Epub 2005/11/22. S1044-7431 (05) 00248-4 [pii] doi: 10. 1016/j.mcn. 2005.10.006 PMID: 16297637.
40. Sahay A, Scobie KN, Hill AS, O'Carroll CM, Kheirbek MA, Burghardt NS, et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature. 2011;472(7344):466-70. Epub 2011/04/05. nature09817 [pii] doi: 10.1038/nature09817 PMID: 21460835; PubMed Central PMCID: PMC3084370.
41. Rolando C, Taylor V. Neural stem cell of the hippocampus: development, physiology regulation, and dysfunction in disease. Curr Top Dev Biol. 2014;107:183-206. Epub 2014/01/21. B978-0-12-416022-4.00007-X [pii] doi: 10.1016/B978-0-12-416022-4.00007-X PMID: 24439807.
42. Urban N, Guillemot F. Neurogenesis in the embryonic and adult brain: same regulators, different roles. Front Cell Neurosci. 2014;8:396. Epub 2014/12/17. doi: 10.3389/fncel.2014.00396 PMID: 25505873; PubMed Central PMCID: PMC4245909.
43. Chapman KZ, Ge R, Monni E, Tatarishvili J, Ahlenius H, Arvidsson A, et al. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke. Neurobiol Dis. 2015;83:1-15. Epub 2015/08/25. S0969-9961 (15) 30033-4 [pii] doi: 10.1016/j.nbd.2015.08.013 PMID: 26299391.
44. Dinel AL, Joffre C, Trifilieff P, Aubert A, Foury A, Le Ruyet P, et al. Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. J Neuroinflammation. 2014;11:155. Epub 2014/09/17. s12974-014-0155-x [pii] doi: 10.1186/s12974-014-0155-x PMID: 25224537; PubMed Central PMCID: PMC4172903.
45. Smith PL, Hagberg H, Naylor AS, Mallard C. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev Neurosci. 2014;36(2):119-31. Epub 2014/03/20. 000359950 [pii] doi: 10.1159/000359950 PMID: 24642725.
46. Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods. 2002;115(1):97-105. Epub 2002/03/19. S0165027002000079 [pii]. doi: 10.1016/s0165-0270 (02) 00007-9 PMID: 11897369.
47. Subramanian M, Timmerman CK, Schwartz JL, Pham DL, Meffert MK. Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci. 2015;9:313. Epub 2015/10/21. doi: 10. 3389/fnins.2015.00313 PMID: 26483618; PubMed Central PMCID: PMC4586332.
48. Casanova MF, Van Kooten IA, Switala AE, Van Engeland H, Heinsen H, Steinbusch HW, et al. Minicolumnar abnormalities in autism. Acta Neuropathol. 2006;112(3):287-303. Epub 2006/07/05. doi: 10. 1007/s00401-006-0085-5 PMID: 16819561.
49. Blatt GJ, Fatemi SH. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec (Hoboken). 2011;294(10):1646-52. Epub 2011/09/09. doi: 10.1002/ar. 21252 PMID: 21901839; PubMed Central PMCID: PMC3190183.
50. Takebayashi H, Ikenaka K. Oligodendrocyte generation during mouse development. Glia. 2015;63(8):1350-6. Epub 2015/05/28. doi: 10.1002/glia.22863 PMID: 26013243.
51. Takano T. Role of Microglia in Autism: Recent Advances. Dev Neurosci. 2015;37(3):195-202. Epub 2015/05/23. 000398791 [pii] doi: 10.1159/000398791 PMID: 25998072.
52. Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J, et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun. 2014;5:5748. Epub 2014/12/11. ncomms6748 [pii] doi: 10.1038/ncomms6748 PMID: 25494366; PubMed Central PMCID: PMC4270294.